Structures by: Pérez S. A.
Total: 7
Chlorido-(N,N-dimethyl(4-fluoro)benzylamine- κN,κC)(dimethylsulfoxide-κS)platinum(II)
C11H17ClFNOPtS
Journal of medicinal chemistry (2015) 58, 3 1320-1336
a=5.9315(3)Å b=12.1005(5)Å c=19.7000(8)Å
α=90.00° β=103.0670(10)° γ=90.00°
Chlorido-(N,N-dimethyl(4-methoxy)benzylamine- κN,κC)-tris(4-trifluoromethylphenyl)phosphane-platinum(II)
C31H26ClF9NOPPt
Journal of medicinal chemistry (2015) 58, 3 1320-1336
a=17.3951(8)Å b=14.9557(7)Å c=11.9109(5)Å
α=90.00° β=98.576(2)° γ=90.00°
Chlorido-(1-methyl-4-isopropyl-benzene)- (N-n-butyl-(para-trifluoromethylphenyl)(methylester)benzimidazol-κN,C)ruthenium(II)
C30H32ClF3N2O2Ru
Journal of medicinal chemistry (2015) 58, 18 7310-7327
a=12.5656(6)Å b=17.1429(8)Å c=13.9971(7)Å
α=90.00° β=108.785(2)° γ=90.00°
Chlorido-(pentamethylcyclopentadienyl)- (N-n-butyl-(para-trifluoromethylphenyl)(methylester)benzimidazol-κN,C)iridium(II)
C30H33ClF3IrN2O2
Journal of medicinal chemistry (2015) 58, 18 7310-7327
a=11.3662(9)Å b=17.1523(13)Å c=15.5280(15)Å
α=90.00° β=111.111(2)° γ=90.00°
Bis(2-phenyl-1H-benzo[d]imidazole-κ^2^N,C)-{methyl 1-butyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxylate-κ^2^N,N}iridium(III) hexafluorophosphate tris(dichloromethane) solvate
C44H37IrN7O2,F6P,3(CH2Cl2)
Chemical communications (Cambridge, England) (2016) 52, 98 14165-14168
a=22.1254(11)Å b=16.4448(9)Å c=28.2843(15)Å
α=90° β=90° γ=90°
Bis(1-phenyl-1H-pyrazole-κ^2^N,C)-{methyl 1-butyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxylate-κ^2^N,N}iridium(III) hexafluorophosphate dichloromethane solvate
C35H29.50IrN7O2,F6P,0.5(CH2Cl2)
Chemical communications (Cambridge, England) (2016) 52, 98 14165-14168
a=24.4157(10)Å b=16.5559(7)Å c=23.3462(9)Å
α=90° β=113.7896(14)° γ=90°
C33H28AuF6N3P2S
C33H28AuF6N3P2S
ACS chemical biology (2017) 12, 6 1524-1537
a=9.5075(4)Å b=10.8348(5)Å c=16.6081(7)Å
α=106.3245(5)° β=95.4554(5)° γ=92.1864(5)°